by Team Small News | Jan 21, 2026 | Divi's Laboratories
A rally emphasizing the importance of road safety was held in Visakhapatnam, India, on Tuesday, with thousands of participants, including employees from Divi’s company, traffic police officials, and local villagers. The event was flagged off by Muralikrishna...
by Team Small News | Jan 16, 2026 | Divi's Laboratories
The Indian pharmaceutical industry is expected to have a mixed third quarter, with domestic formulations and specialty launches driving growth despite US pricing pressure. Companies like Sun Pharmaceuticals and Lupin are likely to lead the way, driven by their...
by Team Small News | Jan 10, 2026 | Divi's Laboratories
Jefferies, a global investment bank, has released its latest report on the Contract Research and Development Manufacturing Organization (CRDMO) sector. The report highlights top picks and revises target prices for several key players in the industry. Sai Life Sciences...
by Team Small News | Jan 8, 2026 | Divi's Laboratories
The Indian pharmaceutical sector is offering investors a chance to build a strong portfolio under the theme “Ayush Kart”, as stated by Siddharth Sedani, Managing Director at Anand Rathi. The Indian pharma sector has been growing rapidly, and this trend is...
by Team Small News | Dec 2, 2025 | Divi's Laboratories
The Biosecure Act has created new opportunities for the Indian pharmaceutical industry. The Act, which aims to regulate the use of biotechnology and ensure the safe handling of biological materials, has opened doors for Indian pharma companies to engage in the...
by Team Small News | Nov 18, 2025 | Divi's Laboratories
Divi’s Laboratories, a leading pharmaceutical company, has successfully cleared a US FDA inspection with zero observations. This significant achievement demonstrates the company’s commitment to quality and compliance with regulatory standards. The...